Drug nanoparticles: formulating poorly water-soluble compounds.
about
Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancerDrug nanocrystals: A way toward scale-upNanomilling of Drugs for Bioavailability Enhancement: A Holistic Formulation-Process Perspective.Recommendations for nanomedicine human subjects research oversight: an evolutionary approach for an emerging fieldSolvent free fabrication of micro and nanostructured drug coatings by thermal evaporation for controlled release and increased effectsEngineered silybin nanoparticles educe efficient control in experimental diabetesAn Intensified Vibratory Milling Process for Enhancing the Breakage Kinetics during the Preparation of Drug Nanosuspensions.Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs.Integration of biosensors and drug delivery technologies for early detection and chronic management of illnessA new theranostic system based on gold nanocages and phase-change materials with unique features for photoacoustic imaging and controlled release.Water-Soluble Derivatives of Octanuclear Iron-Oxo-Pyrazolato Complexes; An Experimental and Computational Study.Preparation and evaluation of tilmicosin-loaded hydrogenated castor oil nanoparticle suspensions of different particle sizesEncapsulation of 16-Hydroxycleroda-3,13-Dine-16,15-Olide in Mesoporous Silica Nanoparticles as a Natural Dipeptidyl Peptidase-4 Inhibitor Potentiated Hypoglycemia in Diabetic Mice.Surface-Modification of Carbonate Apatite Nanoparticles Enhances Delivery and Cytotoxicity of Gemcitabine and Anastrozole in Breast Cancer CellsFormation of Organic Molecular Nanocrystals under Rigid Confinement with Analysis by Solid State NMR.Is the combination of cellulosic polymers and anionic surfactants a good strategy for ensuring physical stability of BCS Class II drug nanosuspensions?Formation of Organic Molecular Nanocrystals under Soft Confinement.Effects of polymer molecular weight on relative oral bioavailability of curcumin.Physical-chemical properties of furosemide nanocrystals developed using rotation revolution mixer.Eudragit-based nanosuspension of poorly water-soluble drug: formulation and in vitro-in vivo evaluationFormulation and particle size reduction improve bioavailability of poorly water-soluble compounds with antimalarial activity.Hybrid nanocrystals: University of Kentucky US20060280680A1.Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs.Enhanced bioavailability of danazol nanosuspensions by wet milling and high-pressure homogenization.In vivo and in vitro antimalarial activity of bergenin.Recent advances in intravenous delivery of poorly water-soluble compounds.Electrospraying, spray drying and related techniques for production and formulation of drug nanoparticles.Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods.Nanomedicine: evolutionary and revolutionary developments in the treatment of certain inflammatory diseases.Has nanotechnology led to improved therapeutic outcomes?Crystalline nanosuspensions as potential toxicology and clinical oral formulations for BCS II/IV compounds.Advances in nanotechnology-based delivery systems for curcumin.Nanocrystals for the parenteral delivery of poorly water-soluble drugsRecent advancements in mechanical reduction methods: particulate systems.Perceptive solutions to anti-filarial chemotherapy of lymphatic filariasis from the plethora of nanomedical sciences.Effect of the surface modification, size, and shape on cellular uptake of nanoparticles.Nanoformulation strategies for the enhanced oral bioavailability of antiretroviral therapeutics.Release kinetics study of poorly water-soluble drugs from nanoparticles: are we doing it right?Improved delivery of poorly soluble compounds using nanoparticle technology: a review.Green synthesis, characterization, and anticancer activity of hyaluronan/zinc oxide nanocomposite.
P2860
Q24614491-ACCC9525-A2E9-4515-B42F-25101A0C1A2CQ26744024-222A28F2-E2FA-4D78-9FF6-98636DEF0BB2Q26746912-EE59826C-28E3-43D6-8175-66027A4F8286Q26822431-5B98A966-AD20-4C72-8C1F-8C720815F253Q28481857-2A4FCDE9-4C0C-4976-8804-56B62A1F3C0AQ28540351-EEB389F2-B5C3-4621-9DF8-588E38DC3BCFQ30375813-8BDC3CA1-09CA-42E5-A7D2-DEAAB82B98C9Q30451024-7B522C9C-3F17-48D6-95E5-A0AFC854D75CQ30451853-A986AD94-045D-4DFC-8185-D44F1CFA47AAQ30468699-61EE28CE-AF08-467D-8B61-E88CA4E02484Q30748546-67E523EE-448C-4EF8-9CBA-7B2DDD6306DEQ33706563-B046A23D-9195-4CE8-B468-B47F20DADF09Q33742245-8FEDCFED-4C9E-4AAB-B86A-D46DD7D384B7Q33850450-91E7C3D6-295A-480A-8F63-BD0252300549Q34222394-EBC5E180-0C8E-405D-A4F4-BF12E95A7442Q35578230-3C1B623B-562A-4678-8EA8-066459DCBBE1Q35981768-AEED0E56-9979-482D-ABFB-45A89277CF05Q36061993-78822170-4158-426A-A877-12FACB54CD24Q36185904-8100D8B5-BC9E-4CB4-A5C0-7E380D1F3182Q36442159-ECB0CD5C-10EE-434A-B7F3-5246D7A7D983Q36882689-A755B202-7AB7-4FC2-A206-497ACAD714A3Q37093395-B780EC63-2217-4CFE-A3F5-A97BB94112B5Q37141404-2ED54BED-56EC-4DCD-ACC3-7C97F93DC932Q37548416-15D15C6F-1015-4AED-8132-2B0E532355E8Q37567769-B29A5BF3-D4D7-4C82-8E07-B1E0FAB1E344Q37639306-719AC9B5-A729-4C60-A618-C0A155629DF6Q37719548-EF816126-0C9B-4B76-8E8F-C7E70470D27AQ37805588-C34B826E-666A-42ED-876C-73D1C49D6113Q37953309-A4462336-F7A3-4EBA-94DC-FFAA63B0A1C7Q37970730-7868699D-E528-4D81-968C-A4515EA6AFDDQ38021953-FF4AC138-A80A-4A15-B137-680E0FC0F581Q38030643-8AC95A71-DB7A-4761-A8BF-17BEDE36B117Q38104343-E119014F-0521-4EBD-AC23-F22AF164537FQ38132471-A29002A2-9F24-4AA8-B0BE-C4B6FD665BA8Q38134133-2D0FC0D6-3B8E-41F2-A3A0-950A703FDD4CQ38384069-3F0E2F51-E5C5-4FD8-9AE8-2C11C0A7CCB4Q38495022-C03BFEEB-0D23-48FC-95A4-925A6F785B01Q38603062-AB283B57-D057-4861-8E3D-44DB97251C09Q38739589-D216E36E-463C-42A3-BCB7-90F4B1C0F577Q38750441-F5F9C420-0BF4-4B8A-BB8D-9825F98D41D7
P2860
Drug nanoparticles: formulating poorly water-soluble compounds.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Drug nanoparticles: formulating poorly water-soluble compounds.
@en
Drug nanoparticles: formulating poorly water-soluble compounds.
@nl
type
label
Drug nanoparticles: formulating poorly water-soluble compounds.
@en
Drug nanoparticles: formulating poorly water-soluble compounds.
@nl
prefLabel
Drug nanoparticles: formulating poorly water-soluble compounds.
@en
Drug nanoparticles: formulating poorly water-soluble compounds.
@nl
P2860
P356
P1476
Drug nanoparticles: formulating poorly water-soluble compounds.
@en
P2093
Elaine M Merisko-Liversidge
Gary G Liversidge
P2860
P356
10.1177/0192623307310946
P407
P577
2008-01-01T00:00:00Z